| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | Dec 16, 2025 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 38.8 | -3,000 | -2.75% | ✓ | $366K |
| Dec 10, 2025 | Dec 11, 2025 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 22.5 | -1,814 | -1.63% | ✗ | $220.1K |
| Nov 17, 2025 | Nov 18, 2025 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 10.0 | -28,000 | -20.71% | ✓ | $3.5M |
| Oct 15, 2025 | Oct 16, 2025 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 38.8 | -3,000 | -2.65% | ✓ | $354.2K |
| Sep 15, 2025 | Sep 16, 2025 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 38.8 | -3,000 | -2.58% | ✓ | $340.7K |
| Sep 10, 2025 | Sep 11, 2025 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 22.5 | -1,819 | -1.54% | ✗ | $209.6K |
| Aug 15, 2025 | Aug 18, 2025 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 32.5 | -28,000 | -3.86% | ✓ | $3.3M |
| Jul 15, 2025 | Jul 16, 2025 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 38.8 | -3,000 | -2.50% | ✓ | $333.1K |
| Jun 16, 2025 | Jun 17, 2025 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 38.8 | -3,000 | -2.44% | ✓ | $330.5K |
| Jun 10, 2025 | Jun 11, 2025 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 22.5 | -1,827 | -1.46% | ✗ | $201.1K |
| May 22, 2025 | May 23, 2025 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 27.5 | -28,000 | -7.04% | ✓ | $3M |
| Mar 10, 2025 | Mar 12, 2025 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 20.0 | -3,907 | -3.05% | ✗ | $457.9K |
| Feb 4, 2025 | Feb 6, 2025 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 100.0 | +44,839 | 59.67% | ✗ | $4.5M |
| Dec 10, 2024 | Dec 11, 2024 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 22.5 | -1,739 | -2.26% | ✗ | $160.6K |
| Nov 6, 2024 | Nov 7, 2024 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 30.0 | -5,000 | -6.40% | ✓ | $456.4K |
| Sep 12, 2024 | Sep 13, 2024 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 5.0 | -29,357 | -27.31% | ✓ | $2.5M |
| Sep 10, 2024 | Sep 11, 2024 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 22.5 | -1,734 | -1.59% | ✗ | $141.2K |
| Aug 28, 2024 | Aug 29, 2024 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 26.3 | -9,513 | -8.27% | ✓ | $742.3K |
| Aug 13, 2024 | Aug 14, 2024 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 35.0 | -5,490 | -4.56% | ✓ | $406.2K |
| Jun 10, 2024 | Jun 11, 2024 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 22.5 | -1,714 | -1.40% | ✗ | $111.8K |
| Mar 10, 2024 | Mar 11, 2024 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 20.0 | -4,559 | -3.71% | ✗ | $342.5K |
| Jan 31, 2024 | Feb 2, 2024 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 100.0 | +51,546 | 83.68% | ✗ | $1.8M |
| Jan 9, 2024 | Jan 10, 2024 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 26.3 | -8,242 | -9.06% | ✓ | $702.5K |
| Dec 10, 2023 | Dec 11, 2023 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 22.5 | -1,247 | -1.35% | ✗ | $98.5K |
| Sep 10, 2023 | Sep 11, 2023 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 22.5 | -1,256 | -1.38% | ✗ | $95.5K |
| Jul 24, 2023 | Jul 25, 2023 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 22.5 | -3,174 | -6.16% | ✗ | $246.5K |
| Jun 10, 2023 | Jun 12, 2023 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 22.5 | -1,272 | -2.81% | ✗ | $99.4K |
| Mar 10, 2023 | Mar 13, 2023 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 20.0 | -5,116 | -5.86% | ✗ | $406.7K |
| Jan 24, 2023 | Jan 26, 2023 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 100.0 | +52,069 | 214.31% | ✗ | $1.3M |
| Dec 10, 2022 | Dec 13, 2022 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 26.3 | -463 | -1.13% | ✗ | $40.7K |
| Sep 10, 2022 | Sep 12, 2022 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 26.3 | -458 | -1.13% | ✗ | $29.9K |
| Jul 24, 2022 | Jul 26, 2022 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 22.5 | -3,206 | -7.53% | ✗ | $194.9K |
| Jun 10, 2022 | Jun 13, 2022 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 26.3 | -462 | -1.30% | ✗ | $28.1K |
| Mar 10, 2022 | Mar 14, 2022 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 22.5 | -3,221 | -8.53% | ✗ | $186.6K |
| Jul 24, 2021 | Jul 27, 2021 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 22.5 | -3,425 | -21.99% | ✗ | $236.4K |
| May 4, 2021 | May 5, 2021 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 17.5 | -19,496 | -70.73% | ✗ | $1.3M |
| Mar 10, 2021 | Mar 12, 2021 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 22.5 | -1,435 | -4.95% | ✗ | $91.7K |
| Nov 3, 2020 | Nov 5, 2020 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 97.5 | +13,988 | 357.02% | ✗ | $722.6K |
| Jul 24, 2020 | Jul 28, 2020 | GILEAD SCIENCES, INC. | Chief Commercial Officer | Sell | 20.0 | -3,587 | -47.79% | ✗ | $264.1K |